LAST NEWS
16 April 2021
Set up of bond financing of up to € 100M over 7 years by OCABSA’s issuance to support the second phase of Europlasma’s development
Read the press release (in French)
2 April 2021
Number of shares and voting rights as at 31/03/2021
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st March. Read the press release (in French)
18 March 2021
Drawdown of the last tranche 15 of 200 convertible notes
Read the press release (in French)
3 March 2021
Number of shares and voting rights as at 28/02/2021
Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February. Read the press release (in French)
24 February 2021
Extraordinary General Meeting of shareholders on 24/02/2021
Results Read the press release (in French)
15 February 2021
Extraordinary General Meeting of shareholders on 24/02/2021
Ad hoc agent appointment Read the press release (in French)
8 February 2021
Information relative to the Extraordinary General Meeting of shareholders on 24/02/2021
Read the press release (in French)
4 February 2021
Number of shares and voting rights as at 31/01/2021
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January. Read the press release (in French)
27 January 2021
Drawdown of the tranche 14 of 200 convertible notes
Read the press release (in French)